Literature DB >> 32239260

HOX gene cluster (de)regulation in brain: from neurodevelopment to malignant glial tumours.

Céline S Gonçalves1,2, Elisa Le Boiteux3, Philippe Arnaud3, Bruno M Costa4,5.   

Abstract

HOX genes encode a family of evolutionarily conserved homeodomain transcription factors that are crucial both during development and adult life. In humans, 39 HOX genes are arranged in four clusters (HOXA, B, C, and D) in chromosomes 7, 17, 12, and 2, respectively. During embryonic development, particular epigenetic states accompany their expression along the anterior-posterior body axis. This tightly regulated temporal-spatial expression pattern reflects their relative chromosomal localization, and is critical for normal embryonic brain development when HOX genes are mainly expressed in the hindbrain and mostly absent in the forebrain region. Epigenetic marks, mostly polycomb-associated, are dynamically regulated at HOX loci and regulatory regions to ensure the finely tuned HOX activation and repression, highlighting a crucial epigenetic plasticity necessary for homeostatic development. HOX genes are essentially absent in healthy adult brain, whereas they are detected in malignant brain tumours, namely gliomas, where HOX genes display critical roles by regulating several hallmarks of cancer. Here, we review the major mechanisms involved in HOX genes (de)regulation in the brain, from embryonic to adult stages, in physiological and oncologic conditions. We focus particularly on the emerging causes of HOX gene deregulation in glioma, as well as on their functional and clinical implications.

Entities:  

Keywords:  Epigenetics; Glioma; Homeobox; Neurodevelopment; Transcriptional regulation

Year:  2020        PMID: 32239260     DOI: 10.1007/s00018-020-03508-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  13 in total

Review 1.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

2.  Integrated Bioinformatic Analysis of the Correlation of HOXA10 Expression with Survival and Immune Cell Infiltration in Lower Grade Glioma.

Authors:  Ting Wang; Mingqian Liu; Ming Jia
Journal:  Biochem Genet       Date:  2022-07-14       Impact factor: 2.220

3.  The Long Non-Coding RNA HOXA-AS2 Promotes Proliferation of Glioma Stem Cells and Modulates Their Inflammation Pathway Mainly through Post-Transcriptional Regulation.

Authors:  Elisa Le Boiteux; Pierre-Olivier Guichet; Konstantin Masliantsev; Bertille Montibus; Catherine Vaurs-Barriere; Céline Gonthier-Gueret; Emmanuel Chautard; Pierre Verrelle; Lucie Karayan-Tapon; Anne Fogli; Franck Court; Philippe Arnaud
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

4.  Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients.

Authors:  Yomna M El-Meligui; Naglaa M Hassan; Amira B Kassem; Nora A Gouda; Marwa Mohanad; Manal A Hamouda; Ahmad Salahuddin
Journal:  Pharmgenomics Pers Med       Date:  2022-06-25

5.  Promoter and enhancer RNAs regulate chromatin reorganization and activation of miR-10b/HOXD locus, and neoplastic transformation in glioma.

Authors:  Evgeny Deforzh; Erik J Uhlmann; Eashita Das; Aleksandra Galitsyna; Ramil Arora; Harini Saravanan; Rosalia Rabinovsky; Aditya D Wirawan; Nadiya M Teplyuk; Rachid El Fatimy; Sucika Perumalla; Anirudh Jairam; Zhiyun Wei; Leonid Mirny; Anna M Krichevsky
Journal:  Mol Cell       Date:  2022-04-06       Impact factor: 19.328

6.  The Prognostic Value and Function of HOXB5 in Acute Myeloid Leukemia.

Authors:  Miao Chen; Yi Qu; Pengjie Yue; Xiaojing Yan
Journal:  Front Genet       Date:  2021-08-05       Impact factor: 4.599

Review 7.  miR-615 Fine-Tunes Growth and Development and Has a Role in Cancer and in Neural Repair.

Authors:  Marisol Godínez-Rubí; Daniel Ortuño-Sahagún
Journal:  Cells       Date:  2020-06-27       Impact factor: 6.600

8.  Clinical Utility of a Unique Genome-Wide DNA Methylation Signature for KMT2A-Related Syndrome.

Authors:  Aidin Foroutan; Sadegheh Haghshenas; Pratibha Bhai; Michael A Levy; Jennifer Kerkhof; Haley McConkey; Marcello Niceta; Andrea Ciolfi; Lucia Pedace; Evelina Miele; David Genevieve; Solveig Heide; Mariëlle Alders; Giuseppe Zampino; Giuseppe Merla; Mélanie Fradin; Eric Bieth; Dominique Bonneau; Klaus Dieterich; Patricia Fergelot; Elise Schaefer; Laurence Faivre; Antonio Vitobello; Silvia Maitz; Rita Fischetto; Cristina Gervasini; Maria Piccione; Ingrid van de Laar; Marco Tartaglia; Bekim Sadikovic; Anne-Sophie Lebre
Journal:  Int J Mol Sci       Date:  2022-02-05       Impact factor: 5.923

9.  Expression of the HOXA gene family and its relationship to prognosis and immune infiltrates in cervical cancer.

Authors:  Fenfen Ge; Weiwei Tie; Junli Zhang; Yingying Zhu; Yingying Fan
Journal:  J Clin Lab Anal       Date:  2021-10-04       Impact factor: 2.352

10.  Widespread overexpression from the four DNA hypermethylated HOX clusters in aggressive (IDHwt) glioma is associated with H3K27me3 depletion and alternative promoter usage.

Authors:  Elisa Le Boiteux; Franck Court; Pierre-Olivier Guichet; Catherine Vaurs-Barrière; Isabelle Vaillant; Emmanuel Chautard; Pierre Verrelle; Bruno M Costa; Lucie Karayan-Tapon; Anne Fogli; Philippe Arnaud
Journal:  Mol Oncol       Date:  2021-05-02       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.